APGE logo

Apogee Therapeutics, Inc. (APGE) Cash From Investing

Annual CFI:

-$300.46M-$26.55M(-9.69%)
December 31, 2024

Summary

  • As of today, APGE annual cash from investing is -$300.46 million, with the most recent change of -$26.55 million (-9.69%) on December 31, 2024.
  • During the last 3 years, APGE annual cash from investing has fallen by -$300.46 million (-100.00%).

Performance

1-Year Change

-9.69%

3-Year Change

-100%

5-Year Change

-100%

15-Year Change

-100%

APGE Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

9%
APGE annual cash from investing is higher than 9% of companies in Healthcare sector

Range

All-Time High

$0.00
APGE annual cash from investing is currently >-9900.00% below its historical high of $0.00

3-Year Low

-$300.46M
APGE annual cash from investing is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
APGE previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 2, 2026
APGE next annual earnings announcement is scheduled for Mar 2, 2026

OtherAPGEcash flow metrics

Annual CFF

$495.11M
APGE annual cash from financing is $495.11 million

Annual CFO

-$171.17M
APGE annual cash from operations is -$171.17 million

Annual FCF

-$172.33M
APGE annual free cash flow is -$172.33 million

Annual CAPEX

$1.15M
APGE annual capital expenditures is $1.15 million

Quarterly CFI:

$17.95M-$60.18M(-77.03%)
September 30, 2025

Summary

  • As of today, APGE quarterly cash from investing is $17.95 million, with the most recent change of -$60.18 million (-77.03%) on September 30, 2025.
  • Over the past year, APGE quarterly cash from investing has increased by +$164.32 million (+112.26%).
  • APGE quarterly cash from investing is now -77.03% below its all-time high of $78.13 million, reached on June 30, 2025.

Performance

3-Month Change

-77.03%

1-Year Change

+112.26%

3-Year Change

+100%

5-Year Change

+100%

APGE Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

87.45%
APGE quarterly cash from investing is higher than 87.45% of companies in Healthcare sector

Range

All-Time High

$78.13M
APGE quarterly cash from investing is currently -77.03% below its historical high of $78.13 million

3-Year Low

-$273.91M
APGE quarterly cash from investing is currently +106.55% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
APGE previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 2, 2026
APGE next earnings announcement is scheduled for Mar 2, 2026

OtherAPGEcash flow metrics

Quarterly CFF

$19.74M
APGE quarterly cash from financing is $19.74 million

Quarterly CFO

-$54.26M
APGE quarterly cash from operations is -$54.26 million

Quarterly FCF

-$54.26M
APGE quarterly free cash flow is -$54.26 million

Quarterly CAPEX

$0.00
APGE quarterly capital expenditures is $0.00

TTM CFI:

$155.42M+$164.32M(+1845.50%)
September 30, 2025

Summary

  • As of today, APGE TTM cash from investing is $155.42 million, with the most recent change of +$164.32 million (+1845.50%) on September 30, 2025.
  • Over the past year, APGE TTM cash from investing has increased by +$776.16 million (+125.04%).
  • APGE TTM cash from investing is now at all-time high.

Performance

3-Month Change

+1845.5%

1-Year Change

+125.04%

3-Year Change

+100%

5-Year Change

+100%

APGE TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

95.94%
APGE TTM cash from investing is higher than 95.94% of companies in Healthcare sector

Range

All-Time High

$155.42M
APGE TTM cash from investing is currently at an all-time high

3-Year Low

-$620.74M
APGE TTM cash from investing is currently +125.04% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
APGE previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 2, 2026
APGE next earnings announcement is scheduled for Mar 2, 2026

OtherAPGEcash flow metrics

TTM CFF

$65.90M
APGE TTM cash from financing is $65.90 million

TTM CFO

-$232.47M
APGE TTM cash from operations is -$232.47 million

TTM FCF

-$237.56M
APGE TTM free cash flow is -$237.56 million

TTM CAPEX

$5.09M
APGE TTM capital expenditures is $5.09 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

APGE Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-9.7%+112.3%+125.0%
3Y3 Years-100.0%+100.0%+100.0%
5Y5 Years-100.0%+100.0%+100.0%

APGE Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year>-9999.0%at low-77.0%+106.5%at high+125.0%
5Y5-Year>-9999.0%at low-77.0%+106.5%at high+125.0%
All-TimeAll-Time>-9999.0%at low-77.0%+106.5%at high+125.0%

APGE Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
$17.95M(-77.0%)
$155.42M(+1845.5%)
Jun 2025
-
$78.13M(+501.8%)
-$8.90M(+96.2%)
Mar 2025
-
$12.98M(-72.0%)
-$235.74M(+21.5%)
Dec 2024
-$300.46M(-9.7%)
$46.37M(+131.7%)
-$300.46M(+51.6%)
Sep 2024
-
-$146.38M(+1.6%)
-$620.74M(-30.9%)
Jun 2024
-
-$148.71M(-187.4%)
-$474.36M(-45.7%)
Mar 2024
-
-$51.74M(+81.1%)
-$325.65M(-18.9%)
DateAnnualQuarterlyTTM
Dec 2023
-$273.91M(>-9900.0%)
-$273.91M(>-9900.0%)
-$273.91M(>-9900.0%)
Sep 2023
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2023
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2023
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2022
$0.00
-
-
Sep 2022
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2022
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2022
-
$0.00
$0.00

FAQ

  • What is Apogee Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Apogee Therapeutics, Inc.?
  • What is Apogee Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Apogee Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Apogee Therapeutics, Inc.?
  • What is Apogee Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Apogee Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Apogee Therapeutics, Inc.?
  • What is Apogee Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Apogee Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of APGE is -$300.46M

What is the all-time high annual cash from investing for Apogee Therapeutics, Inc.?

Apogee Therapeutics, Inc. all-time high annual cash from investing is $0.00

What is Apogee Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, APGE annual cash from investing has changed by -$26.55M (-9.69%)

What is Apogee Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of APGE is $17.95M

What is the all-time high quarterly cash from investing for Apogee Therapeutics, Inc.?

Apogee Therapeutics, Inc. all-time high quarterly cash from investing is $78.13M

What is Apogee Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, APGE quarterly cash from investing has changed by +$164.32M (+112.26%)

What is Apogee Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of APGE is $155.42M

What is the all-time high TTM cash from investing for Apogee Therapeutics, Inc.?

Apogee Therapeutics, Inc. all-time high TTM cash from investing is $155.42M

What is Apogee Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, APGE TTM cash from investing has changed by +$776.16M (+125.04%)
On this page